180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · Real-Time Price · USD
3.540
+0.260 (7.93%)
At close: Aug 1, 2025, 4:00 PM
3.230
-0.310 (-8.76%)
After-hours: Aug 1, 2025, 7:59 PM EDT
United States Steel Market Cap
180 Life Sciences has a market cap or net worth of $21.38 million as of August 1, 2025. Its market cap has increased by 871.76% in one year.
Market Cap
21.38M
Enterprise Value
20.57M
1-Year Change
871.76%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since June 27, 2017, 180 Life Sciences's market cap has decreased from $125.60M to $21.38M, a decrease of -82.98%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 19.80M | 450.00% |
| Dec 31, 2024 | 3.60M | 125.00% |
| Dec 29, 2023 | 1.60M | -76.81% |
| Dec 30, 2022 | 6.90M | -94.80% |
| Dec 31, 2021 | 132.70M | 169.72% |
| Dec 31, 2020 | 49.20M | -43.64% |
| Dec 31, 2019 | 87.30M | -42.45% |
| Dec 31, 2018 | 151.70M | 4.98% |
| Dec 29, 2017 | 144.50M | 15.05% |
| Jun 27, 2017 | 125.60M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.37B |
| Johnson & Johnson | 402.99B |
| AbbVie | 344.84B |
| AstraZeneca | 228.08B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.69B |
| Novo Nordisk | 211.90B |